Security key
451033708
iBio, Inc. - Common Stock, par value $0.001 per share (IBIO)
CUSIP: 451033708
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock, par value $0.001 per share
- Total 13F shares
- 2,451,117
- Total 13F value
- $5,171,853
- Share change
- -433,680
- SEC-reported price per share
- $2.11
- Number of holders
- 26
- Value change
- -$1,674,085
- Number of buys
- 8
- Number of sells
- 13
- Shares outstanding
- 117,033,737
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
26
Top holders
10
IBIO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2024
Previous quarter: Q1 2024
iBio, Inc. SEC filings
iBio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 451033708
Recent filing periods:
Ownership snapshot
Top reported holders of IBIO - iBio, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Opaleye Management Inc.
Disclosed value leader
Opaleye Management Inc.
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 0.58%
Showing 1-6 of 15 holder rows.
Quick read
Opaleye Management Inc. leads the comparable SEC ownership view at 0.58%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Opaleye Management Inc.'s linked filing trail.
Comparable ownership
Top 5
Opaleye Management Inc.
0.58%
Ikarian Capital, LLC
0.51%
Lynx1 Capital Management LP
0.51%
ADAR1 Capital Management, LLC
0.51%
ARMISTICE CAPITAL, LLC
0.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Opaleye Management Inc. |
13F
Company
|
0.58%
|
$2,760,800
680,000 shares
|
— | 31 Mar 2024 |
| Ikarian Capital, LLC |
13F
Company
|
0.51%
|
$2,436,000
600,000 shares
|
— | 31 Mar 2024 |
| Lynx1 Capital Management LP |
13F
Company
|
0.51%
|
$2,436,000
600,000 shares
|
— | 31 Mar 2024 |
| ADAR1 Capital Management, LLC |
13F
Company
|
0.51%
|
$2,192,400
600,000 shares
|
— | 31 Mar 2024 |
| ARMISTICE CAPITAL, LLC |
13F
Company
|
0.3%
|
$1,424,561
350,877 shares
|
— | 31 Mar 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0.01%
|
$64,000
15,879 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
26
Shares
2,451,117
Rows available
26
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
26
Q2 2024 holders
26
Holder diff
0
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend